Neuphoria Therapeutics Inc.

Nasdaq:NEUP

Pharmaceutical Preparations·BURLINGTON, MA

Governanceproxy statements · beneficial ownership

Proxy Statements

15 shown

Filed	Form	Description
12/8/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
12/4/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
12/1/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
11/25/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
11/24/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
11/24/25	DEFC14A	DEFC14A	→
↓

Ownership Filings

32 shown

Filed	Form	Description
1/21/26	4	4	→
1/21/26	4	4	→
1/21/26	4	4	→
1/21/26	4	4	→
10/23/25	4	4	→
10/23/25	3	3	→
↓